Insider Trading Activity For Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX)
Michael Bonner , CFO of Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) reportedly Bought 500 shares of the company’s stock at an average price of 6.72 for a total transaction amount of $3,360.00 SEC Form
Insider Trading History For Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX)
On 3/19/2014 Thomas Lawrence, Director, sold 20,000 with an average share price of $4.54 per share and the total transaction amounting to $90,800.00.View SEC Filing
On 8/21/2014 Thomas R Lawrence, Director, sold 15,000 with an average share price of $5.08 per share and the total transaction amounting to $76,200.00.View SEC Filing
On 11/20/2014 Thomas R Lawrence, Director, sold 10,000 with an average share price of $5.12 per share and the total transaction amounting to $51,200.00.View SEC Filing
On 3/19/2015 Thomas R Lawrence, Director, sold 6,000 with an average share price of $6.95 per share and the total transaction amounting to $41,700.00.View SEC Filing
On 11/19/2015 Thomas R Lawrence, Director, sold 4,000 with an average share price of $5.61 per share and the total transaction amounting to $22,440.00.View SEC Filing
On 5/26/2016 Thomas R Lawrence, Director, sold 3,000 with an average share price of $4.55 per share and the total transaction amounting to $13,650.00.View SEC Filing
On 8/17/2016 Thomas R Lawrence, Director, sold 3,000 with an average share price of $4.60 per share and the total transaction amounting to $13,800.00.View SEC Filing
Analyst Ratings For Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX)
These are No ratings tracked in the last 12 months. .
The current consensus rating for Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) is N/A (Score: NaN) with a consensus target price of N/A
Recent Trading Activity for Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX)
Shares of Cumberland Pharmaceuticals Inc. closed the previous trading session at 7.10 up +0.29 4.26% with 25,602 shares trading hands.